Yarui Li

Yarui Li

Auto-generated profile, based on publicly available information

Yarui Li

Department of Gastroenterology The First Affiliated Hospital of Xi'an Jiaotong University China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2019 in Cell Proliferation
Verified
Journal Article
Open access
PDF file
DGDan Guo
Dan Guo
YLYarui Li
Yarui Li
YCYifei Chen
Yifei Chen
DZDan Zhang
Dan Zhang
XWXin Wang
Xin Wang
SHShuixiang He
Shuixiang He
Objectives: This research aims to verify that the long non‐coding RNA differentiation antagonizing nonprotein coding RNA (LncRNA DANCR) could modulate the proliferation and metastasis of hepatocellular carcinoma (HCC), and it thus may work as a novel biomarker to render new orientation for early diagnosis and clinical therapy of HCC.Materials and methods: Firstly, qRT‐PCR was used to detect the expression of genes including LncRNA DANCR and miR‐27a‐3p. Next, MTT assay, Ethynyldeoxyuridine (EdU) analysis and clone formation assay were used for investigating cell growth and proliferation. Meanwhile, transwell assay and wound healing assay were applied to evaluate the capacity of cell metastasis and motility, respectively. In addition, bioinformatic analysis and dual‐luciferase reporter assay were applied to analyse molecular interaction. Next, we conducted immunofluorescence and Western blot for mechanic investigation. Last but not the least, xenograft tumours in nude mice were built by subcutaneously injecting Hep3B cells stably transfected with sh‐NC and sh‐DANCR to detect proliferation and SMMC‐7721 cells stably transfected with sh‐NC and sh‐DANCR to investigate metastasis.Results: The results of qRT‐PCR and bioinformatic analysis revealed the high expression of DANCR in HCC. DANCR accelerated proliferation and metastasis of HCC cells and the knockdown of DANCR had the opposite effect. Meanwhile, xenograft tumours in sh‐DANCR group grow slower and have smaller volumes compared with negative control group. Next, the antineoplastic effect of miR‐27a‐3p on cell growth and motility of HCC was confirmed. In addition, we clarified that DANCR acted as a ceRNA to decoy miR‐27a‐3p via mediating ROCK1/LIMK1/COFILIN1 pathway. In the end, we validated that DANCR/miR‐27a‐3p axis regulates EMT progression by cell immunofluorescence and Western blot.Conclusions: In a word, DANCR promotes HCC development and induces EMT by decoying miR‐27a‐3p to regulate ROCK1/LIMK1/COFILIN1 pathway.

25 March 2022 in Cancer Gene Therapy
Verified
Journal Article
Open access
PDF file
YLYarui Li
Yarui Li
JHJunbi Hu
Junbi Hu
DGDan Guo
Dan Guo
WMWenhui Ma
Wenhui Ma
XZXu Zhang
Xu Zhang
SHShuixiang He
Shuixiang He
The role of long noncoding RNA (lncRNAs) had been demonstrated in different types of cancer, including hepatocellular carcinoma. This study was intended to investigate the role of lncRNA small nucleolar RNA host gene 5 (SNHG5) in HCC proliferation and the liver CSC-like properties. Through functional experiments, we determined that knockdown of SNHG5 repressed HCC cell proliferation and CSC-like properties, while over-expression of SNHG5 promoted cell growth. At the same time, CSC markers (CD44, CD133, and ALDH1) and related transcription factors (OCT4, SOX2, and NANOG) were downregulated when SNHG5 was knocked down. Mechanically, RNA immunoprecipitation (RIP) and RNA pulldown assay showed that SNHG5 regulated the proliferation and CSC-like properties of HCC by binding UPF1. Further investigations showed that expression of critical components of Wnt/β-catenin pathway (β-catenin, TCF4, c-myc, cyclinD1, and c-Jun) were upregulated with depletion of UPF1 in liver CSCs, which were downregulated with depletion of SNHG5. After use of the inhibitor of Wnt/β-catenin pathway, the formation of liver CSCs sphere decreased. Taken together, SNHG5 plays a critical role to promote HCC cell proliferation and cancer stem cell-like properties via UPF1 and Wnt/β-catenin pathway.

2 July 2019 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
YLYarui Li
Yarui Li
DGDan Guo
Dan Guo
MRMudan Ren
Mudan Ren
YZYan Zhao
Yan Zhao
XWXin Wang
Xin Wang
SHShuixiang He
Shuixiang He
Emerging evidence has indicated that deregulation of long non‐coding RNAs (lncRNAs) can contribute to the progression of human cancers, including hepatocellular carcinoma (HCC). However, the role and exact mechanism of most lncRNAs in tumours remains largely unknown. In the current study, we found a novel long non‐coding RNA termed SNAI3‐AS1 which was generally up‐regulated in HCC tissues compared with normal control. Higher expression of SNAI3‐AS1 was significantly correlated with shorter overall survival of HCC patients. Knockdown of SNAI3‐AS1 inhibited the proliferation and metastasis of HCC cells in vitro, whereas overexpression of SNAI3‐AS1 promoted the proliferation and metastasis of HCC cells. Further investigations showed that SNAI3‐AS1 could affect HCC tumorigenesis by binding up‐frameshift protein 1 (UPF1), regulating Smad7 expression and activating TGF‐β/Smad pathway. Functionally, SNAI3‐AS1 promoted HCC growth and metastasis by inducing tumour epithelial to mesenchymal transition (EMT). Taken together, these findings showed that SNAI3‐AS1 promotes the progression of HCC by regulating the UPF1 and activating TGF‐β/Smad pathway.

10 June 2022 in The FEBS Journal
Verified
Journal Article
Closed access
RWRuhua Wang
Ruhua Wang
YFYunong Fu
Yunong Fu
MYMenglin Yao
Menglin Yao
XCXiaomeng Cui
Xiaomeng Cui
YZYan Zhao
Yan Zhao
SHShuixiang He
Shuixiang He

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
YZYan Zhao
Yan Zhao
MRMudan Ren
Mudan Ren
GLGuifang Lu
Guifang Lu
XLXinlan Lu
Xinlan Lu
YYYan Yin
Yan Yin
SHShuixiang He
Shuixiang He
Background. Acute variceal bleeding is a major cause of death in liver cirrhosis. This large scale retrospective cohort study aims to analyze the prognosis of patients with cirrhosis and acute variceal bleeding and to validate the current prognostic models. Methods. Patients with cirrhosis and acute variceal bleeding were enrolled from Jan 2019 to March 2020. The independent prognostic factors for in‐hospital death were identified by logistic regression analyses. Area under curves (AUCs) was compared among Child‐Pugh, cirrhosis acute gastrointestinal bleeding (CAGIB) score, and model for end‐stage liver disease (MELD) and neutrophil‐lymphocyte ratio (NLR) scores. Results. Overall, 379 patients with liver cirrhosis and acute variceal bleeding were consecutively evaluated. The majority of the patients were males (59.1%) and the mean age of all patients were 53.7 ± 1.3 years (range 14‐89). Hepatitis B virus (HBV) was the most common underlying cause of liver cirrhosis (54.1%). 72 (19%) patients had hepatocellular carcinoma. Multivariate logistic regression analyses showed that age, HCC, WBC, total serum bilirubin, serum creatinine, and ALT were independently associated with in‐hospital death. And the odds ratios (ORs) for in‐hospital death were 1.066 (95% CI 1.017‐1.118, P = 0.008), 7.19 (95% CI 2.077‐24.893, P = 0.001), 1.123 (95% CI 1.051‐1.201, P = 0.001), 1.014 (95% CI 1.005‐1.023, P = 0.003), 1.012 (95% CI 1.004‐1.021, P = 0.006), and 1.005 (95% CI 1.000‐1.009, P = 0.036), respectively. In the whole cohort with HCC patients, the AUCs of Child‐Pugh, CAGIB, MELD and NLR scores were 0.842 (95% CI 0.801‐0.878), 0.840 (95% CI 0.799‐0.876), 0.798 (95% CI 0.754‐0.838), and 0.688 (95% CI 0.639‐0.735), respectively. The differences were statistically significant between Child‐Pugh and NLR scores (P = 0.0118), and between CAGIB and NLR scores (P = 0.0354). Conclusion. Child‐Pugh and CAGIB scores showed better predictive performance for prognosis of patients with cirrhosis and acute variceal bleeding than NLR scores.

19 February 2020 in Research Square
Verified
Preprint
Open access
PDF file
YLYarui Li
Yarui Li
JHJunbi Hu
Junbi Hu
GLGuifang Lu
Guifang Lu
MRMudan Ren
Mudan Ren
ZZZhiyong Zhang
Zhiyong Zhang
SHShuixiang He
Shuixiang He
Background: It have been revealed that lncRNAs had a critical role in human cancers, including HCC. Our previous study found a lncRNA SNHG5 related to the development of HCC. However, the role and exact mechanism of SNHG5 in HCC proliferation and the liver CSC-like properties is still unclear. Materials and Methods: We investigated the HCC cells proliferation and CSC-like properties in vitro and in vivo by knockdown or upregulate SNHG5, and detected underlying mechanisms by qRT-PCR, Western blotting, bioinformatic analysis, luciferase reporter assay, RNA immunoprecipitation. Results: Knockdown of SNHG5 repressed HCC cells proliferation and CSC-like properties, while overexpression of SNHG5 promoted cells growth. At the same time, CSCs markers ( CD44, CD133 and ALDH1) and related transcription factors (OCT4, SOX2 and NANOG) were downregulated when SNHG5 knockdown. Further investigations showed that SNHG5 regulated the proliferation and CSC-like properties of HCC by binding UPF1 and regulating Wnt/β-catenin pathway. Conclusions: SNHG5 plays critical role to promote HCC cells proliferation and cancer stem cell-like properties via UPF1 and Wnt/β-catenin pathway.